Since COX-2 inhibitors are reported to be both chemoprotective and helpful in treatment of breast cancer [31], the COX-2 inhibitory potential (Ki) of the phytochemicals selected for the study were compared to standard NSAID controls such as ibuprofen, aspirin and paracetamol. The gene discussed is PTGS2; the disease is breast cancer.